OSTEOCIS

This brand name is authorized in Spain, France, Hong Kong, Ireland, Malta, United Kingdom

Active ingredients

The drug OSTEOCIS contains one active pharmaceutical ingredient (API):

1 Technetium ⁹⁹ᵐTc oxidronic acid UNII H852YK87WP - OXIDRONATE DISODIUM

Technetium ⁹⁹ᵐTc oxidronic acid is a radiopharmaceutical agent. A radiopharmaceutical is defined as a medicinal formulation containing radioisotopes that are used in major clinical areas for diagnosis and/or therapy. Technetium ⁹⁹ᵐTc oxidronic acid is indicated as a skeletal imaging agent in adults and children to delineate areas of abnormal osteogenesis, such as those that occur with metastatic bone disease, Paget’s disease, arthritic disease, osteomyelitis, and fractures. Read about Technetium ⁹⁹ᵐTc oxidronic acid

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
OSTEOCIS Kit for radiopharmaceutical preparation	Health Products Regulatory Authority (IE)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
V09BA01	Technetium (99mTc) oxidronic acid	V Various → V09 Diagnostic radiopharmaceuticals → V09B Skeleton → V09BA Technetium (99mTc) compounds
Discover more medicines within V09BA01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 76639
Country: FR	Base de données publique des médicaments	Identifier(s): 63521034
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 394723
Country: HK	Department of Health Drug Office	Identifier(s): 43123
Country: MT	Medicines Authority	Identifier(s): AA826/00701